| 4690 |
Centers for Disease Control and Prevention |
Html |
en |
Commute times, food retail gaps, and body mass index in North Carolina counties |
null |
| North Carolina | 0.448328 |
| commute time | 0.390185 |
| rural residents | 0.380633 |
| North Carolina Department | 0.21281 |
| special food services | 0.206743 |
| county-level independent variables | 0.201504 |
| county-level food sales | 0.226185 |
| individual-level bmi | 0.282425 |
| county-level variables | 0.21118 |
| mean county-level commute | 0.262666 |
| county-level BMI | 0.272693 |
| county-level mean BMI | 0.318146 |
| longer commute times | 0.221117 |
| BMI | 0.325295 |
| average commute time | 0.208621 |
|
| drinking places | 0.245558 |
| commute times | 0.635556 |
| NAICS code | 0.211841 |
| specialty food stores | 0.222786 |
| county-level sales | 0.221783 |
| food retail gap | 0.925332 |
| county-level retail sales | 0.206841 |
| county-level commute time | 0.290969 |
| North Carolina counties | 0.274497 |
| county-level commute times | 0.355083 |
| food retail gaps | 0.320831 |
| county-level diversity index | 0.20896 |
| county-level demand | 0.231366 |
| capita | 0.273709 |
|
CLICK HERE |
| 4997 |
Centers for Disease Control and Prevention |
Html |
en |
Heart Disease Home Page |
null |
| CDC VITAL SIGNS | 0.651046 |
| coronary artery disease | 0.647238 |
| common type | 0.461966 |
| pharmacist | 0.377175 |
| key scientific papers | 0.586648 |
| Heart Disease Quiz | 0.679848 |
| health outcomes | 0.463482 |
| health disparities | 0.463387 |
| sodium reduction | 0.709738 |
| organ function | 0.450382 |
| New research | 0.447712 |
| 6-question quiz | 0.447915 |
| blood pressure | 0.552757 |
| risk factors | 0.451918 |
| Key Scientific Abstracts | 0.589311 |
| Healthy Heart Podcast | 0.626317 |
| Added Sugar Intake | 0.607638 |
| CAD | 0.3477 |
| Internal Medicine | 0.447368 |
| health care costs | 0.583879 |
| blood cholesterol | 0.491187 |
| scientific studies | 0.455335 |
| CDC’s Division | 0.466576 |
| new data | 0.477416 |
|
| public health strategies | 0.59782 |
| heart health | 0.52403 |
| heart disease death | 0.669 |
| heart attack | 0.525719 |
| Science Behind Sodium | 0.50787 |
| United States | 0.462157 |
| vaccines | 0.373252 |
| dietary sodium | 0.504425 |
| adults | 0.359094 |
| heart-healthy living | 0.460159 |
| cardiac arrest | 0.787346 |
| STROKE DEATHS Access | 0.659088 |
| wide sodium reduction | 0.64476 |
| lifestyle changes | 0.453679 |
| heart disease | 0.968877 |
| American Heart | 0.505078 |
| key papers | 0.453559 |
| main types | 0.467425 |
| Stroke Prevention | 0.46831 |
| CDC scientists | 0.47222 |
| U.S. The risk | 0.451835 |
| Dr. Derrick Gervin | 0.584734 |
| cardiovascular diseases | 0.837291 |
| Cardiovascular Diseases Mortality | 0.825583 |
|
CLICK HERE |
| 9291 |
Centers for Disease Control and Prevention |
Html |
es |
CDC - Preventing Chronic Disease: Volume 9, 2012: 12_0039 |
CDC - Wide Page example description goes here |
| comunidades mi’kmaq | 0.938716 |
| jóvenes aborigen | 0.770394 |
| fuerte deseo | 0.725744 |
| juventud aborigen | 0.807049 |
|
| Cabo Bretón | 0.753855 |
| frÃo extremo | 0.737748 |
| comunidad mi’kmaq | 0.711291 |
| Estados Unidos | 0.7124 |
|
CLICK HERE |
| 9360 |
Centers for Disease Control and Prevention |
Html |
es |
Eficacia del programa de control y prevención de enfermedades crónicas "Pasos Adelante" en una comunidad en la frontera de EE. UU. y México, 2005-2008 |
CDC - Wide Page example description goes here |
| Hispanic border population | 0.304356 |
| Pasos Adelante | 0.975085 |
| Prev Med | 0.313389 |
| Human Kinetic Books | 0.30386 |
| US Census Bureau | 0.30393 |
| seguro médico | 0.313236 |
| programa pasos | 0.309762 |
| Mexican Americans | 0.306861 |
| Level Beam Scale | 0.304241 |
| Vital Statistics Reports | 0.303871 |
| altas hospitalarias | 0.307345 |
| diabetes with | 0.307888 |
| obesity among us | 0.304276 |
| United States-Mexico border | 0.304297 |
| Estados Unidos | 0.305719 |
| Health Care Poor | 0.305117 |
| lifestyle interventions | 0.307718 |
| Obes Relat Metab | 0.303945 |
| community health | 0.307686 |
| US-Mexico border community | 0.305877 |
| Flegal KM | 0.307515 |
| among subjects with | 0.304446 |
| chronic disease prevention | 0.316108 |
| caracterÃsticas demográficas | 0.307904 |
| United States | 0.306574 |
|
| successful community coalition-university | 0.304377 |
| Douglas community health | 0.306307 |
| alto riesgo | 0.307144 |
| Curtin LR | 0.306973 |
| diabetes mellitus | 0.307457 |
| disease risk | 0.306889 |
| Community Health Partnersh | 0.305533 |
| Ogden CL | 0.306699 |
| salud community outreach | 0.305147 |
| Salud Pública | 0.313917 |
| diabetes tipo | 0.308596 |
| Cardinal Scale Manufacturing | 0.304075 |
| health care | 0.307334 |
| antecedentes familiares | 0.306077 |
| Diabetes Care | 0.308115 |
| Carroll MD | 0.3061 |
| Stewart R | 0.306657 |
| control among mexican | 0.30473 |
| An ecological perspective | 0.304254 |
| physical activity | 0.306998 |
| Zapien J | 0.30577 |
| Rev Panam Salud | 0.304821 |
| Womens Health | 0.303867 |
| Diabetes Prevention Program | 0.309503 |
|
CLICK HERE |
| 10411 |
Centers for Disease Control and Prevention |
Html |
en |
Roadmap for State Program Planning - Evaluate the Program'State Resources'DHDSP'CDC |
null |
| Chronic Disease Practice | 0.629389 |
| public health issues | 0.615798 |
| state capacity | 0.542937 |
| American Evaluation Association | 0.680124 |
| evaluation | 0.937236 |
| evaluation plan | 0.854878 |
| professional association | 0.58986 |
| National HDSP Program | 0.664601 |
| appropriate data collection | 0.645159 |
| surveillance data | 0.528051 |
| Basic Implementation Programs | 0.597896 |
| evaluation design | 0.590154 |
| CDC Evaluation Framework | 0.697046 |
| future activities | 0.557368 |
| evaluation planning— | 0.58499 |
| data integrity | 0.542848 |
| work plan objectives | 0.613952 |
| Chronic Disease Directors | 0.629619 |
| evaluate program | 0.679532 |
| capacity building activities | 0.823785 |
| chronic disease | 0.810068 |
| evaluation expectations | 0.575182 |
| HDSP program evaluation | 0.783994 |
| HDSP Evaluation Plan | 0.789963 |
| evaluation areas | 0.569767 |
|
| Gather credible evidence | 0.604783 |
| annual Work Plan | 0.613876 |
| Basic Implementation | 0.61695 |
| qualitative data | 0.544146 |
| program area | 0.560639 |
| state level data | 0.629943 |
| evaluation guides | 0.568121 |
| systematic collection | 0.530056 |
| Systematically document HDS | 0.607113 |
| state HDSP program | 0.864162 |
| Evaluate progress | 0.540661 |
| evaluation results | 0.580846 |
| state partnership | 0.608713 |
| Evaluate program achievements | 0.671017 |
| outcome evaluation | 0.579777 |
| Prevention Research Centers | 0.608819 |
| evaluation should— | 0.574056 |
| state HDSP programs | 0.646492 |
| program logic model | 0.631707 |
| health department program | 0.647179 |
| sample evaluation questions | 0.656359 |
| interventions | 0.530566 |
| Document changes | 0.610653 |
| Report program results | 0.678646 |
|
CLICK HERE |
| 13370 |
Centers for Disease Control and Prevention |
Html |
en |
Information for Health Care Workers | Rat-bite Fever (RBF) |CDC |
null |
| Spirillum minus | 0.592867 |
| diagnosis assistance | 0.349598 |
| gram-negative microaerophilic bacillus | 0.590191 |
| pleomorphic gram-negative bacilli | 0.529052 |
| North America | 0.383047 |
| rodent exposure | 0.380331 |
| rat-bite fever | 0.524699 |
| Recent case reports | 0.472357 |
| severe nausea/vomiting | 0.36162 |
| RBF | 0.992699 |
| characteristic spirochetes | 0.364356 |
| Streptobacillus moniliformis | 0.566834 |
| body fluids | 0.348574 |
| infected rodent | 0.408287 |
| incidence rates | 0.357316 |
| preliminary diagnosis | 0.352634 |
| state public health | 0.46335 |
| maculopapular rash | 0.402834 |
| distinct rash | 0.394079 |
| Person-to-person transmission | 0.374664 |
| nationally notifiable disease | 0.47721 |
| normal respiratory flora | 0.519663 |
| United States | 0.345649 |
| natural reservoir | 0.364429 |
| appropriate specimens | 0.464556 |
|
| Haverhill fever | 0.754032 |
| rodent species | 0.397142 |
| S. moniliformis | 0.937049 |
| Accurate data | 0.346047 |
| incubation period | 0.378627 |
| differential stains | 0.34583 |
| motile spirochete | 0.413623 |
| S. minus | 0.420297 |
| incubation conditions | 0.362119 |
| fever onset | 0.478596 |
| red plaques | 0.353843 |
| potential risk | 0.34816 |
| untreated RBF | 0.69899 |
| common symptoms | 0.361821 |
| mortality rate | 0.348635 |
| Following partial healing | 0.476928 |
| positive culture | 0.34776 |
| disease incidence | 0.356641 |
| rat bite | 0.361391 |
| synovial fluid | 0.351658 |
| Initial symptoms | 0.366155 |
| infected animal | 0.365841 |
| specific media | 0.349932 |
| darkfield microscopy | 0.343958 |
|
CLICK HERE |
| 13392 |
Centers for Disease Control and Prevention |
Html |
null |
Vaccines: VPD-VAC/Pneumo/In-Short |
Pneumococcal In Short: Description, Symptoms, Complications, Transmission, Vaccine, etc. |
|
|
CLICK HERE |
| 13397 |
Centers for Disease Control and Prevention |
Html |
en |
State Tobacco Control Program Spending - United States,2011 |
Please note: An erratum has been published for this article. To view the erratum, please click here. |
| smokeless tobacco advertising | 0.511088 |
| tobacco tax revenues | 0.516013 |
| tobacco-related health care | 0.456133 |
| community interventions | 0.500333 |
| program component | 0.485308 |
| state general funds | 0.462764 |
| expenditure data | 0.473968 |
| cessation interventions | 0.500621 |
| tobacco control programs | 0.918232 |
| funding levels | 0.472214 |
| additional state experiences | 0.463451 |
| cigarette excise taxes | 0.477402 |
| direct expenditures | 0.455119 |
| comprehensive tobacco control | 0.758569 |
| tobacco prevention | 0.699422 |
| substantial state government | 0.456275 |
| tobacco products | 0.51702 |
| state cigarette excise | 0.463366 |
| health communication | 0.484788 |
| Best Practices | 0.550417 |
| statewide tobacco control | 0.550084 |
| tobacco control landscape | 0.538647 |
| relevant state organizations | 0.463778 |
| tobacco control funding | 0.557397 |
| United States | 0.531525 |
|
| State Public Health | 0.461479 |
| state investments | 0.45453 |
| states | 0.585742 |
| health communication interventions | 0.474794 |
| overall expenditures | 0.459412 |
| tobacco-related disease | 0.456216 |
| tobacco taxes | 0.486151 |
| 50 states | 0.543577 |
| state tobacco control | 0.705126 |
| Best Practices levels | 0.454225 |
| tobacco industry master | 0.516941 |
| tobacco control expenditures | 0.598404 |
| tobacco control program | 0.583771 |
| evidence-based state tobacco | 0.546182 |
| tobacco control policies | 0.524162 |
| control funding data | 0.462291 |
| tobacco companies | 0.490508 |
| smokeless tobacco | 0.535285 |
| control activities | 0.495836 |
| funding tobacco prevention | 0.529955 |
| recommended state funding | 0.477373 |
| capita expenditures | 0.466086 |
| evidence-based interventions | 0.462709 |
| tobacco control | 0.968064 |
|
CLICK HERE |
| 16169 |
Centers for Disease Control and Prevention |
Html |
en |
HPV Vaccine Information For Young Women |
HPV - STD information from CDC. Fact Sheets, Statistics, Treatment Guidelines, Resources for Clinicians and Educators. |
| HPV types— | 0.203411 |
| HPV vaccination | 0.344921 |
| HPV test | 0.237064 |
| HPV vaccine | 0.80765 |
| HPV types | 0.486735 |
| cervical cancer | 0.691177 |
| targeted HPV types | 0.242999 |
|
| HPV | 0.931484 |
| genital warts | 0.28749 |
| Genital HPV | 0.246161 |
| HPV infection | 0.23045 |
| HPV vaccines | 0.211736 |
| HPV infections | 0.202104 |
|
CLICK HERE |
| 16460 |
Centers for Disease Control and Prevention |
Html |
en |
Characteristics of Electronic Cigarette Use Among Middle andHigh School Students - United States, 2015 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| e-cigarette advertising | 0.386574 |
| complex survey design | 0.383411 |
| conventional cigarettes | 0.381949 |
| multiple device types | 0.379791 |
| e-cigarette brands | 0.406684 |
| comprehensive tobacco control | 0.455588 |
| product types | 0.46234 |
| nicotine exposure | 0.426682 |
| U.S. Surgeon General | 0.386633 |
| commonly used e-cigarette | 0.45294 |
| response rate | 0.3836 |
| tobacco product dependence | 0.394422 |
| tobacco products | 0.456261 |
| public health practice | 0.392917 |
| commonly reported brand | 0.497195 |
| prevention strategies | 0.378352 |
| e-cigarette product types | 0.425031 |
| Connecticut high school | 0.391616 |
| U.S. middle | 0.520845 |
| United States | 0.438236 |
| Drug Administration | 0.389259 |
| youths | 0.611918 |
| products | 0.458892 |
| Hispanic students | 0.398656 |
|
| nicotine delivery | 0.396715 |
| nationally representative sample | 0.38035 |
| U.S. students | 0.378488 |
| tobacco product | 0.633647 |
| brands | 0.43107 |
| middle school students | 0.427365 |
| substances | 0.384343 |
| rechargeable/refillable e-cigarettes | 0.53826 |
| e-cigarette users | 0.440235 |
| commonly reported brands | 0.421561 |
| certain e-cigarette marketers | 0.400269 |
| high school students | 0.982371 |
| e-cigarettes | 0.820511 |
| National Youth Tobacco | 0.402011 |
| U.S. youths | 0.533109 |
| Nicotine content | 0.391399 |
| relative standard error | 0.380805 |
| commonly used tobacco | 0.573958 |
| high school students.* | 0.401242 |
| Table). | 0.39851 |
| NYTS response rate | 0.380165 |
| disposable e-cigarettes | 0.44469 |
| heavily advertised e-cigarette | 0.402367 |
| non-Hispanic black students | 0.48868 |
|
CLICK HERE |